Lista de obras -

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer ⬇️

scientific article published on 04 June 2019

A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology

artículo científico publicado en 2022

Adjuvant Chemotherapy in Colon Cancer: Ageism or Appropriate Care? ⬇️

artículo científico publicado el 18 de julio de 2011

Adolescent and young adult colorectal cancer

artículo científico

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

artículo científico publicado en 2017

Alternate dosing of cetuximab for patients with metastatic colorectal cancer ⬇️

artículo científico publicado el 1 de marzo de 2013

Antiangiogenesis agents in colorectal cancer

scientific article published on July 2010

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology

artículo científico publicado en 2019

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set

artículo científico publicado en 2009

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

artículo científico publicado en 2018

Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer

artículo científico publicado en 2020

Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data set

artículo científico publicado en 2012

Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice

artículo científico publicado en 2015

Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report

artículo científico publicado en 2021

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).

artículo científico publicado en 2017

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

artículo científico publicado en 2018

Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer

artículo científico publicado en 2015

Clinical update on K-Ras targeted therapy in gastrointestinal cancers

artículo científico publicado en 2018

Colorectal cancer in 2014: progress in defining first-line and maintenance therapies

artículo científico

Colorectal cancer: how emerging molecular understanding affects treatment decisions

artículo científico publicado en 2014

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

artículo científico publicado en 2020

Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer

artículo científico

Incorporating biomarkers into cancer and aging research

artículo científico publicado en 2014

Incorporating biomarkers of frailty and senescence in cancer therapeutic trials

artículo científico

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer

artículo científico publicado en 2016

Management of Colorectal Cancer in Older Adults

artículo científico publicado en 2015

Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases ⬇️

artículo científico publicado el 29 de octubre de 2011

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

artículo científico publicado en 2016

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

artículo científico publicado en 2020

Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor

artículo científico

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.

artículo científico publicado en 2017

Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

artículo científico publicado en 2020

Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper.

artículo científico publicado en 2018

Optimizing biologic sequencing in metastatic colorectal cancer: first line and beyond

artículo científico publicado en 2019

Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience

scientific article published on 19 April 2018

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

artículo científico publicado en 2014

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

artículo científico publicado en 2010

Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies

artículo científico publicado en 2015

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

artículo científico publicado en 2016

Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice

artículo científico publicado en 2014

Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

artículo científico publicado en 2017

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

artículo científico publicado en 2016

Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years

artículo científico publicado en 2017

Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma

scientific article published on 14 July 2020

Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers

artículo científico publicado en 2015

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 September 2019

Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma

scientific article published on 28 April 2020

Systemic therapy for elderly patients with gastrointestinal cancer.

artículo científico publicado en 2011

The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials

artículo científico publicado en 2015

The Management of Older Adults with Pancreatic Adenocarcinoma.

artículo científico publicado en 2018

The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

artículo científico publicado en 2019

The challenge to optimize medical therapy for advanced colorectal cancer

artículo científico publicado en 2014

The diagnosis and outcome of Krukenberg tumors

artículo científico publicado en 2021

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study

artículo científico publicado en 2020

Treatment of liver-limited metastatic colorectal cancer

artículo científico publicado en 2010

When less is more: maintenance therapy in colorectal cancer

artículo científico publicado en 2015

Lista de obras de

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer ⬇️

A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology

Adjuvant Chemotherapy in Colon Cancer: Ageism or Appropriate Care? ⬇️

Adolescent and young adult colorectal cancer

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Alternate dosing of cetuximab for patients with metastatic colorectal cancer ⬇️

Antiangiogenesis agents in colorectal cancer

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer

Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data set

Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice

Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer

Clinical update on K-Ras targeted therapy in gastrointestinal cancers

Colorectal cancer in 2014: progress in defining first-line and maintenance therapies

Colorectal cancer: how emerging molecular understanding affects treatment decisions

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer

Incorporating biomarkers into cancer and aging research

Incorporating biomarkers of frailty and senescence in cancer therapeutic trials

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer

Management of Colorectal Cancer in Older Adults

Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases ⬇️

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.

Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence

Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper.

Optimizing biologic sequencing in metastatic colorectal cancer: first line and beyond

Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice

Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years

Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma

Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology

Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Systemic therapy for elderly patients with gastrointestinal cancer.

The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials

The Management of Older Adults with Pancreatic Adenocarcinoma.

The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

The challenge to optimize medical therapy for advanced colorectal cancer

The diagnosis and outcome of Krukenberg tumors

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study

Treatment of liver-limited metastatic colorectal cancer

When less is more: maintenance therapy in colorectal cancer